MOPRX Holdings — MainStay Epoch U.S. Small Cap Fund
All 140 reported holdings of MainStay Epoch U.S. Small Cap Fund (MOPRX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Xometry, Inc. | 3.34% | $11.45M |
| Enova International, Inc. | 2.59% | $8.90M |
| Lundin Mining Corp. | 2.56% | $8.79M |
| Kaiser Aluminum Corp. | 2.46% | $8.45M |
| Laureate Education, Inc. | 2.44% | $8.36M |
| Fortrea Holdings, Inc. | 2.22% | $7.63M |
| DigitalOcean Holdings, Inc. | 2.20% | $7.57M |
| Blue Bird Corp. | 2.18% | $7.50M |
| Hexcel Corp. | 2.18% | $7.47M |
| Integer Holdings Corp. | 2.05% | $7.03M |
| NetScout Systems, Inc. | 2.03% | $6.96M |
| TTM Technologies, Inc. | 1.99% | $6.83M |
| Greif, Inc. | 1.99% | $6.82M |
| Excelerate Energy, Inc. | 1.84% | $6.32M |
| A10 Networks, Inc. | 1.83% | $6.26M |
| Macerich Co. (The) | 1.80% | $6.17M |
| Sensata Technologies Holding plc | 1.79% | $6.13M |
| Tower Semiconductor Ltd. | 1.66% | $5.69M |
| Remitly Global, Inc. | 1.64% | $5.63M |
| Waystar Holding Corp. | 1.62% | $5.54M |
| Power Integrations, Inc. | 1.61% | $5.53M |
| DNOW, Inc. | 1.60% | $5.48M |
| Centuri Holdings, Inc. | 1.58% | $5.41M |
| Life Time Group Holdings, Inc. | 1.57% | $5.39M |
| SailPoint, Inc. | 1.56% | $5.34M |
| ICF International, Inc. | 1.55% | $5.33M |
| CareTrust REIT, Inc. | 1.54% | $5.29M |
| Champion Homes, Inc. | 1.48% | $5.08M |
| Ingram Micro Holding Corp. | 1.44% | $4.95M |
| Old National Bancorp | 1.43% | $4.91M |
| Flywire Corp. | 1.41% | $4.85M |
| Vishay Intertechnology, Inc. | 1.37% | $4.69M |
| New Jersey Resources Corp. | 1.33% | $4.57M |
| Southwest Gas Holdings, Inc. | 1.32% | $4.52M |
| Upbound Group, Inc. | 1.30% | $4.45M |
| Materion Corp. | 1.27% | $4.34M |
| Bandwidth, Inc. | 1.24% | $4.26M |
| Maximus, Inc. | 1.23% | $4.21M |
| Nextpower, Inc. | 1.16% | $3.99M |
| Federal Agricultural Mortgage Corp. | 1.13% | $3.89M |
| WSFS Financial Corp. | 1.11% | $3.82M |
| Ameresco, Inc. | 1.10% | $3.79M |
| Atlas Energy Solutions, Inc. | 1.09% | $3.76M |
| Advance Auto Parts, Inc. | 1.09% | $3.75M |
| First Bancorp | 1.07% | $3.67M |
| Helix Energy Solutions Group, Inc. | 1.05% | $3.62M |
| Cushman & Wakefield Ltd. | 1.05% | $3.59M |
| Banner Corp. | 1.02% | $3.50M |
| Invesco Govt And Agcy Lex | 0.94% | $3.23M |
| United Community Banks, Inc. | 0.89% | $3.04M |
| Artivion, Inc. | 0.89% | $3.04M |
| First Interstate BancSystem, Inc. | 0.88% | $3.01M |
| Tfdxx Lex Blackrock Fed Fund | 0.87% | $3.00M |
| Prosperity Bancshares, Inc. | 0.85% | $2.90M |
| Renasant Corp. | 0.84% | $2.87M |
| Enterprise Financial Services Corp. | 0.83% | $2.86M |
| Tidewater, Inc. | 0.83% | $2.85M |
| TransMedics Group, Inc. | 0.78% | $2.67M |
| Cytokinetics, Inc. | 0.49% | $1.67M |
| Freshpet, Inc. | 0.47% | $1.60M |
| Krystal Biotech, Inc. | 0.43% | $1.47M |
| Alkermes plc | 0.39% | $1.34M |
| NYLIM U.S. Government Liquidity Fund | 0.39% | $1.32M |
| Protagonist Therapeutics, Inc. | 0.38% | $1.31M |
| Praxis Precision Medicines, Inc. | 0.38% | $1.30M |
| TG Therapeutics, Inc. | 0.36% | $1.22M |
| Spyre Therapeutics, Inc. | 0.35% | $1.19M |
| Vaxcyte, Inc. | 0.33% | $1.14M |
| Cogent Biosciences, Inc. | 0.30% | $1.03M |
| Xenon Pharmaceuticals, Inc. | 0.28% | $977.21K |
| Kymera Therapeutics, Inc. | 0.28% | $963.27K |
| Definium Therapeutics, Inc. | 0.27% | $929.28K |
| Ligand Pharmaceuticals, Inc. | 0.27% | $913.23K |
| PTC Therapeutics, Inc. | 0.26% | $894.67K |
| Liquidia Corp. | 0.26% | $890.56K |
| CG oncology, Inc. | 0.25% | $868.80K |
| Twist Bioscience Corp. | 0.25% | $858.56K |
| Scholar Rock Holding Corp. | 0.25% | $852.59K |
| Dianthus Therapeutics, Inc. | 0.25% | $844.67K |
| Rhythm Pharmaceuticals, Inc. | 0.25% | $843.53K |
| Mirum Pharmaceuticals, Inc. | 0.24% | $832.13K |
| iShares Russell 2000 ETF | 0.24% | $827.59K |
| Travere Therapeutics, Inc. | 0.24% | $810.29K |
| Indivior Pharmaceuticals, Inc. | 0.22% | $769.83K |
| Oruka Therapeutics, Inc. | 0.22% | $749.79K |
| CRISPR Therapeutics AG | 0.21% | $706.12K |
| Tango Therapeutics, Inc. | 0.19% | $656.48K |
| Veracyte, Inc. | 0.17% | $598.18K |
| Erasca, Inc. | 0.17% | $584.85K |
| Denali Therapeutics, Inc. | 0.16% | $539.04K |
| ACADIA Pharmaceuticals, Inc. | 0.15% | $527.20K |
| Dyne Therapeutics, Inc. | 0.15% | $526.59K |
| Immunovant, Inc. | 0.15% | $526.00K |
| Relay Therapeutics, Inc. | 0.15% | $519.50K |
| Celcuity, Inc. | 0.15% | $512.84K |
| Amneal Pharmaceuticals, Inc. | 0.15% | $507.13K |
| Kiniksa Pharmaceuticals International plc | 0.15% | $498.75K |
| Arcutis Biotherapeutics, Inc. | 0.14% | $496.21K |
| Celldex Therapeutics, Inc. | 0.14% | $476.85K |
| Ideaya Biosciences, Inc. | 0.14% | $475.17K |
| Edgewise Therapeutics, Inc. | 0.13% | $445.06K |
| GRAIL, Inc. | 0.13% | $441.05K |
| ImmunityBio, Inc. | 0.13% | $429.88K |
| Arcus Biosciences, Inc. | 0.12% | $409.29K |
| Beam Therapeutics, Inc. | 0.12% | $401.10K |
| Supernus Pharmaceuticals, Inc. | 0.12% | $394.80K |
| Prestige Consumer Healthcare, Inc. | 0.11% | $385.54K |
| Enliven Therapeutics, Inc. | 0.11% | $382.24K |
| Tarsus Pharmaceuticals, Inc. | 0.11% | $378.86K |
| Vericel Corp. | 0.11% | $374.57K |
| Immunome, Inc. | 0.11% | $371.85K |
| Nektar Therapeutics | 0.11% | $370.45K |
| Ultragenyx Pharmaceutical, Inc. | 0.10% | $356.24K |
| SELLAS Life Sciences Group, Inc. | 0.10% | $353.15K |
| Alumis, Inc. | 0.10% | $349.96K |
| Disc Medicine, Inc. | 0.10% | $349.66K |
| VeraDermics, Inc. | 0.10% | $348.92K |
| Nurix Therapeutics, Inc. | 0.10% | $339.28K |
| Vera Therapeutics, Inc. | 0.10% | $329.92K |
| BioCryst Pharmaceuticals, Inc. | 0.09% | $322.06K |
| Trevi Therapeutics, Inc. | 0.09% | $316.40K |
| Amylyx Pharmaceuticals, Inc. | 0.09% | $311.35K |
| MBX Biosciences, Inc. | 0.09% | $299.92K |
| ADMA Biologics, Inc. | 0.09% | $298.65K |
| Aurinia Pharmaceuticals, Inc. | 0.08% | $289.83K |
| Biohaven Ltd. | 0.08% | $289.29K |
| Agios Pharmaceuticals, Inc. | 0.08% | $281.35K |
| Syndax Pharmaceuticals, Inc. | 0.08% | $275.67K |
| Ocular Therapeutix, Inc. | 0.08% | $266.15K |
| Viridian Therapeutics, Inc. | 0.08% | $264.14K |
| Palvella Therapeutics, Inc. | 0.08% | $263.06K |
| Innoviva, Inc. | 0.08% | $261.47K |
| ANI Pharmaceuticals, Inc. | 0.08% | $259.67K |
| Iovance Biotherapeutics, Inc. | 0.08% | $257.99K |
| Stoke Therapeutics, Inc. | 0.07% | $247.76K |
| Sarepta Therapeutics, Inc. | 0.07% | $232.04K |
| Recursion Pharmaceuticals, Inc. | 0.07% | $231.49K |
| Intellia Therapeutics, Inc. | 0.06% | $217.25K |
| Monte Rosa Therapeutics, Inc. | 0.05% | $186.23K |
| Canadian Dollar | 0.00% | $-0 |
MOPRX overview: performance, fees, allocation and SEC filings